Bank of Montreal
AEGR

Bank of Montreal’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bank of Montreal’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24,639
Closed -$91K – 4520
2016
Q1 		$91K Buy
24,639
+24,493
+16,776% +$152K ﹤0.01% 2838
2015
Q4 		$1K Buy
+146
New +$1.76K ﹤0.01% 4168
2014
Q4 		– Sell
-214,390
Closed -$7.16M – 4289
2014
Q3 		$7.16M Sell
214,390
-82,826
-28% -$2.57M 0.01% 956
2014
Q2 		$9.54M Buy
297,216
+37,506
+14% +$1.4M 0.01% 823
2014
Q1 		$12M Buy
259,710
+50,252
+24% +$2.95M 0.02% 593
2013
Q4 		$14.9M Buy
209,458
+206,790
+7,751% +$15.8M 0.02% 463
2013
Q3 		$229K Buy
+2,668
New +$226K ﹤0.01% 2180

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bank of Montreal's AEGR Position: Q2 2016 in Review

Bank of Montreal sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 24,639 shares — an estimated $91K sold.

Bank of Montreal first reported a position in AEGR in Q3 2013 and held it in 7 quarters. The position peaked at $14.9M in Q4 2013. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

  • Bank of Montreal reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Bank of Montreal sold 24,639 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $91K.
  • Bank of Montreal first reported a position in Aegerion Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Bank of Montreal's Aegerion Pharmaceuticals position peaked at $14.9M in Q4 2013.
  • 71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on Bank of Montreal's 13F filing for Q2 2016, filed 25 Jul 2016.